Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 18, 2024

BUY
$1.71 - $3.06 $40,981 - $73,335
23,966 New
23,966 $66,000
Q4 2022

Jan 17, 2023

BUY
$2.25 - $4.67 $42,441 - $88,090
18,863 New
18,863 $47,000
Q1 2022

Apr 07, 2022

SELL
$4.63 - $9.94 $84,039 - $180,420
-18,151 Closed
0 $0
Q3 2021

Jan 13, 2022

BUY
$10.13 - $15.0 $4,761 - $7,050
470 Added 2.66%
18,151 $194,000
Q1 2021

May 10, 2021

SELL
$14.49 - $20.72 $14,939 - $21,362
-1,031 Reduced 5.51%
17,681 $287,000
Q3 2020

Oct 15, 2020

BUY
$13.67 - $17.77 $80,393 - $104,505
5,881 Added 45.83%
18,712 $277,000
Q2 2020

Jul 07, 2020

BUY
$10.89 - $21.47 $139,729 - $275,481
12,831 New
12,831 $189,000

Others Institutions Holding HRTX

About HERON THERAPEUTICS, INC.


  • Ticker HRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 118,774,000
  • Market Cap $184M
  • Description
  • Heron Therapeutics, Inc., a biotechnology company, engages in developing treatments to address unmet patient needs. The company's product candidates utilize its proprietary Biochronomer, a drug delivery technology, which delivers therapeutic levels of a range of short-acting pharmacological agents over a period from days to weeks with a single a...
More about HRTX
Track This Portfolio

Track Diversified Trust CO Portfolio

Follow Diversified Trust CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Diversified Trust CO, based on Form 13F filings with the SEC.

News

Stay updated on Diversified Trust CO with notifications on news.